BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Gland Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
543245
ISIN Demat
INE068V01023
Book Value (Rs)
655.2871714
NSE Symbol
GLAND
Divident Yield %
0.71
Market Cap
(Rs In Cr.)
46,220
P/E (TTM)
32.72
EPS (TTM)
85.62
Face Value
(Rs)
1
Back
Gland Pharma consolidated net profit rises 47.09% in the June 2026 quarter
10-Aug-26   Hrs IST

Net profit of Gland Pharma rose 47.09% to Rs 316.96 crore in the quarter ended June 2026 as against Rs 215.48 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 1800.27 crore in the quarter ended June 2026 as against Rs 1505.62 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales1800.271505.62 20
OPM %27.1824.43 -
PBDT546.23413.79 32
PBT434.98312.74 39
NP316.96215.48 47

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)